Beta cell function during rapamycin monotherapy in long-term type 1 diabetes

Diabetologia

Volumn 54, Issue 2, 2011, Pages 433-439

  Piemonti, L ^a   Maffi, P ^a   Monti, L ^a   Lampasona, V ^a   Perseghin, G ^a,b   Magistretti, P ^a   Secchi, A ^a,c   Bonifacio, E ^a,d  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^d CENTER FOR REGENERATIVE THERAPIES DRESDEN   (Germany)

Author keywords

C peptide; Humans; Long term type 1 diabetes; Rapamycin

Indexed keywords

C PEPTIDE; GLUTAMATE DECARBOXYLASE ANTIBODY; INSULIN; INSULIN ANTIBODY; PROINSULIN; RAPAMYCIN;

ACNE; ADULT; ANTIBODY TITER; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; DISEASE DURATION; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MENSTRUAL IRREGULARITY; MONOTHERAPY; MOUTH ULCER; PANCREAS ISLET CELL FUNCTION; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; PROTEINURIA; SIDE EFFECT;

ADULT; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INSULIN-SECRETING CELLS; MALE; MIDDLE AGED; PROINSULIN; SIROLIMUS;

EID: 78951480815     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-010-1959-6     Document Type: Article

References (29)

1. EH Liu BJ Digon 3rd B Hirshberg, et al. 2009 Pancreatic beta cell function persists in many patients with chronic type 1 diabetes, but is not dramatically improved by prolonged immunosuppression and euglycaemia from a beta cell allograft Diabetologia 52 1369 1380 1:CAS:528:DC%2BD1MXms1yhs7s%3D 10.1007/s00125-009-1342-7 19418039
2. KI Rother LM Spain RA Wesley, et al. 2009 Effects of exenatide alone and in combination with daclizumab on beta-cell function in long-standing type 1 diabetes Diabetes Care 32 2251 2257 1:CAS:528:DC%2BC3cXktlWqtA%3D%3D 10.2337/dc09-0773 19808924
3. A Kuroda Y Yamasaki A Imagawa 2003 Beta-cell regeneration in a patient with type 1 diabetes mellitus who was receiving immunosuppressive therapy Ann Intern Med 139 W81 14623642
4. C Eff O Faber T Deckert 1978 Persistent insulin secretion, assessed by plasma C-peptide estimation in long-term juvenile diabetics with a low insulin requirement Diabetologia 15 169 172 1:STN:280:DyaE1M%2FisFertQ%3D%3D 10.1007/BF00421234 359394
5. S Madsbad 1983 Prevalence of residual B cell function and its metabolic consequences in type 1 (insulin-dependent) diabetes Diabetologia 24 141 147 1:STN:280:DyaL3s7otleluw%3D%3D 6341142
6. The Diabetes Control and Complications Trial Research Group 1998 Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial Ann Intern Med 128 517 523
7. S Madsbad OK Faber C Binder P McNair C Christiansen I Transbol 1978 Prevalence of residual beta-cell function in insulin-dependent diabetics in relation to age at onset and duration of diabetes Diabetes 27 Suppl 1 262 264 344117
8. MW Steffes S Sibley M Jackson W Thomas 2003 Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial Diab Care 26 832 836 10.2337/diacare.26.3.832
9. AK Foulis CN Liddle MA Farquharson JA Richmond RS Weir 1986 The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom Diabetologia 29 267 274 1:STN:280:DyaL283kvVCgtw%3D%3D 10.1007/BF00452061 3522324
10. W Gepts J De Mey 1978 Islet cell survival determined by morphology. An immunocytochemical study of the islets of Langerhans in juvenile diabetes mellitus Diabetes 27 Suppl 1 251 261 75815
11. Y Stefan L Orci F Malaisse-Lagae A Perrelet Y Patel RH Unger 1982 Quantitation of endocrine cell content in the pancreas of nondiabetic and diabetic humans Diabetes 31 694 700 1:STN:280:DyaL3s7jt12jsA%3D%3D 10.2337/diabetes.31.8.694 6131002
12. M Lohr G Kloppel 1987 Residual insulin positivity and pancreatic atrophy in relation to duration of chronic type 1 (insulin-dependent) diabetes mellitus and microangiopathy Diabetologia 30 757 762 1:STN:280:DyaL1c7ht1Gmsw%3D%3D 10.1007/BF00275740 3322901
13. JJ Meier A Bhushan AE Butler RA Rizza PC Butler 2005 Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration? Diabetologia 48 2221 2228 1:CAS:528:DC%2BD2MXht1Skt7vJ 10.1007/s00125-005-1949-2 16205882
14. SC Kent Y Chen L Bregoli, et al. 2005 Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope Nature 435 224 228 1:CAS:528:DC%2BD2MXktVWhtb0%3D 10.1038/nature03625 15889096
15. GG Pinkse OH Tysma CA Bergen, et al. 2005 Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes Proc Natl Acad Sci USA 102 18425 18430 1:CAS:528:DC%2BD28Xpt1Gl 10.1073/pnas.0508621102 16339897
16. I Yokota J Matsuda E Naito M Ito K Shima Y Kuroda 1998 Comparison of GAD and ICA512/IA-2 antibodies at and after the onset of IDDM Diabetes Care 21 49 52 1:STN:280:DyaK1c7pvFOqtA%3D%3D 10.2337/diacare.21.1.49 9538970
17. E Simone GS Eisenbarth 1996 Chronic autoimmunity of type I diabetes Horm Metab Res 28 332 336 1:CAS:528:DyaK28XlsVSjsrs%3D 10.1055/s-2007-979808 8858379
18. C Jaeger J Allendorfer E Hatziagelaki, et al. 1997 Persistent GAD 65 antibodies in longstanding IDDM are not associated with residual beta-cell function, neuropathy or HLA-DR status Horm Metab Res 29 510 515 1:CAS:528:DyaK2sXntlaqs78%3D 10.1055/s-2007-979091 9405979
19. AS Levey JP Bosch JB Lewis T Greene N Rogers D Roth 1999 A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group Ann Intern Med 130 461 470 1:CAS:528:DyaK1MXitFChs7k%3D 10075613
20. V Lampasona A Petrone C Tiberti, et al. 2010 Zinc transporter 8 antibodies complement GAD and IA-2 antibodies in the identification and characterization of adult-onset autoimmune diabetes: Non Insulin Requiring Autoimmune Diabetes (NIRAD) 4 Diabetes Care 33 104 108 1:CAS:528: DC%2BC3cXht1KitLc%3D 10.2337/dc08-2305 19808923
21. C Torn PW Mueller M Schlosser E Bonifacio PJ Bingley Participating Laboratories 2008 Diabetes Antibody Standardization Program: evaluation of assays for autoantibodies to glutamic acid decarboxylase and islet antigen-2 Diabetologia 51 846 852 1:STN:280:DC%2BD1c3jt1Knsg%3D%3D 10.1007/s00125-008- 0967-2 18373080
22. CJ Greenbaum AM Anderson LM Dolan, et al. 2009 Preservation of beta-cell function in autoantibody-positive youth with diabetes Diabetes Care 32 1839 1844 1:CAS:528:DC%2BD1MXhtlehs7nM 10.2337/dc08-2326 19587365
23. A Pugliese D Brown D Garza, et al. 2001 Self-antigen-presenting cells expressing diabetes-associated autoantigens exist in both thymus and peripheral lymphoid organs J Clin Invest 107 555 564 1:CAS:528:DC%2BD3MXhs12ns7o%3D 10.1172/JCI10860 11238556
24. O Johnston CL Rose AC Webster JS Gill 2008 Sirolimus is associated with new-onset diabetes in kidney transplant recipients J Am Soc Nephrol 19 1411 1418 10.1681/ASN.2007111202 18385422
25. A Teutonico PF Schena S Di Paolo 2005 Glucose metabolism in renal transplant recipients: effect of calcineurin inhibitor withdrawal and conversion to sirolimus J Am Soc Nephrol 16 3128 3135 1:CAS:528:DC%2BD2MXhtFegtLbI 10.1681/ASN.2005050487 16107580
26. M Fraenkel M Ketzinel-Gilad Y Ariav, et al. 2008 mTOR inhibition by rapamycin prevents beta-cell adaptation to hyperglycemia and exacerbates the metabolic state in type 2 diabetes Diabetes 57 945 957 1:CAS:528: DC%2BD1cXksVGkuro%3D 10.2337/db07-0922 18174523
27. HJ Cho J Park HW Lee YS Lee JB Kim 2004 Regulation of adipocyte differentiation and insulin action with rapamycin Biochem Biophys Res Commun 321 942 948 1:CAS:528:DC%2BD2cXmt1OgtL0%3D 10.1016/j.bbrc.2004.07.050 15358118
28. E Bell X Cao JA Moibi, et al. 2003 Rapamycin has a deleterious effect on MIN-6 cells and rat and human islets Diabetes 52 2731 2739 1:CAS:528: DC%2BD3sXovVagt7s%3D 10.2337/diabetes.52.11.2731 14578291
29. L Plum HV Lin R Dutia, et al. 2009 The obesity susceptibility gene Cpe links FoxO1 signaling in hypothalamic pro-opiomelanocortin neurons with regulation of food intake Nat Med 15 1195 1201 1:CAS:528:DC%2BD1MXhtFGjt7jJ 10.1038/nm.2026 19767734